You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Secondary Progressive Multiple Sclerosis, primary progressive multiple sclerosis

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Sclerosis, Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Secondary Progressive Trial in Palo Alto

Not yet recruiting
  • Multiple Sclerosis
  • +2 more
  • KYV-101 anti-CD19 CAR-T cell therapy
  • Standard lymphodepletion regimen
  • Palo Alto, California
    Stanford Multiple Sclerosis Center
Nov 13, 2023

Multiple Sclerosis (MS) Patients

Not yet recruiting
  • Multiple Sclerosis, Relapsing-Remitting
  • +2 more
    • (no location specified)
    Dec 15, 2022

    Multiple Sclerosis, Primary Progressive Multiple Sclerosis, Secondary-progressive Multiple Sclerosis Trial in Belgium (Metformin

    Not yet recruiting
    • Multiple Sclerosis
    • +2 more
    • Metformin Hydrochloride 850 mg Oral Tablet
    • Placebo
    • Brugge, Belgium
    • +4 more
    May 30, 2023

    Progressive Multiple Sclerosis Trial in Lille, Strasbourg (Placebo, Masitinib (4.5))

    Recruiting
    • Progressive Multiple Sclerosis
    • Placebo
    • Masitinib (4.5)
    • Lille, France
    • +1 more
    Jul 1, 2022

    Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Secondary Progressive, Multiple Sclerosis, Primary Progressive

    Completed
    • Multiple Sclerosis, Relapsing-Remitting
    • +2 more
    • 18F-DPA-714 and 18F-FDG
    • Paris, France
    • +1 more
    Sep 14, 2022

    Primary Progressive Multiple Sclerosis, Secondary Progressive Multiple Sclerosis, Multiple Sclerosis Trial (Intranasal Foralumab

    Withdrawn
    • Primary Progressive Multiple Sclerosis
    • +2 more
    • Intranasal Foralumab Solution
    • Placebo
    • (no location specified)
    Feb 14, 2022

    Secondary Progressive Multiple Sclerosis, Primary Progressive Multiple Sclerosis Trial in Los Angeles (Metformin 500 Mg Oral

    Recruiting
    • Secondary Progressive Multiple Sclerosis
    • Primary Progressive Multiple Sclerosis
    • Metformin 500 Mg Oral Tablet, up to 4 tablets a day
    • Placebo oral tablet identical to metformin, up to 4 tablets a day
    • Los Angeles, California
      University of California, Los Angeles
    May 2, 2022

    Multiple Sclerosis, Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Secondary Progressive Trial in San Francisco

    Recruiting
    • Multiple Sclerosis
    • +2 more
    • N-acetyl cysteine
    • Placebo
    • San Francisco, California
      University of California, San Francisco
    Mar 22, 2022

    Secondary Progressive Multiple Sclerosis, Primary Progressive Multiple Sclerosis, Progressive Relapsing Multiple Sclerosis Trial

    Active, not recruiting
    • Secondary Progressive Multiple Sclerosis
    • +2 more
    • Minneapolis, Minnesota
    • +2 more
    Mar 29, 2022

    Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Secondary Progressive Trial in Marseille, Rennes (Magnetic

    Recruiting
    • Multiple Sclerosis, Primary Progressive
    • Multiple Sclerosis, Secondary Progressive
    • Magnetic Resonance Imaging
    • +3 more
    • Marseille, France
    • +1 more
    Jan 14, 2022

    Multiple Sclerosis, Chronic Progressive, Multiple Sclerosis, Multiple Sclerosis, Primary Progressive Trial in Porto Alegre

    Not yet recruiting
    • Multiple Sclerosis, Chronic Progressive
    • +3 more
    • Nordic Walking (NWG)
    • +2 more
    • Porto Alegre, Rio Grande Do Sul, Brazil
      Universidade Federal do Rio Grande do Sul
    May 17, 2022

    Relapsing Remitting Multiple Sclerosis, Primary Progressive Multiple Sclerosis, Secondary Progressive Multiple Sclerosis Trial

    Recruiting
    • Relapsing Remitting Multiple Sclerosis
    • +2 more
    • Ixazomib (NINLARO®) capsules / Matching placebo capsules
    • London, Greater London, United Kingdom
      Royal London Hospital, Barts Health NHS Foundation Trust
    Feb 17, 2022

    MS-ResearchBiomarkerS

    Recruiting
    • Multiple Sclerosis
    • +10 more
      • Los Angeles, California
        Cedars-Sinai Medical Center
      Jan 26, 2022

      Imaging Interplay Between Axonal Damage and Repair in Multiple

      Recruiting
      • Multiple Sclerosis (MS)
      • +3 more
      • MRI
      • +2 more
      • Basel, Switzerland
        University Hospital Basel, Department of Neurology
      Dec 15, 2021

      Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Secondary Progressive, Multiple Sclerosis, Primary Progressive

      Completed
      • Multiple Sclerosis, Relapsing-Remitting
      • +2 more
      • Baltimore, Maryland
        Johns Hopkins University School of Medicine
      Dec 30, 2021

      Primary Progressive Multiple Sclerosis, Secondary Progressive Multiple Sclerosis, Relapsing Multiple Sclerosis Trial in Boston

      Recruiting
      • Primary Progressive Multiple Sclerosis
      • +3 more
      • Boston, Massachusetts
        Brigham and Women's Hospital
      Jul 20, 2021

      Primary Progressive Multiple Sclerosis, Secondary Progressive Multiple Sclerosis Trial in Australia, Canada, United States

      Active, not recruiting
      • Primary Progressive Multiple Sclerosis
      • Secondary Progressive Multiple Sclerosis
      • ATA188
      • Placebo
      • La Jolla, California
      • +33 more
      Jul 21, 2022

      Relapsing Remitting Multiple Sclerosis, Secondary Progressive Multiple Sclerosis, Primary Progressive Multiple Sclerosis Trial

      Recruiting
      • Relapsing Remitting Multiple Sclerosis
      • +2 more
      • Glostrup, Copenhagen, Denmark
      • +11 more
      May 3, 2022

      Progressive Multiple Sclerosis Trial in Thessaloniki (Early Harvest Extra Virgin Olive Oil)

      Completed
      • Progressive Multiple Sclerosis
      • Early Harvest Extra Virgin Olive Oil
      • Thessaloniki, Macedonia, Greece
        A' Department of Neurology,Aristotle University of Thessaloniki
      Jul 4, 2021

      Multiple Sclerosis, Secondary Progressive, Multiple Sclerosis Trial in Warsaw (Cladribine Subcutaneous Injection, 0.9% Chloride

      Recruiting
      • Multiple Sclerosis, Secondary Progressive
      • Multiple Sclerosis
      • Cladribine Subcutaneous Injection
      • 0.9% Chloride Injection Sodium
      • Warsaw, Mazowieckie, Poland
        Institute of Psychiatry and Neurology
      Jul 26, 2023

      Mitochondrial Dysfunction in Primary Progressive Multiple

      Recruiting
      • Multiple Sclerosis
        • Milan, MI, Italy
        • +1 more
        Aug 29, 2023

        Multiple Sclerosis Trial in Berlin (Sunphenon EGCG, Placebo)

        Completed
        • Multiple Sclerosis
        • Sunphenon EGCG
        • Placebo
        • Berlin, Germany
          Charité Universitätsmedizin Berlin (NeuroCure Clinical Research
        Jul 28, 2021

        Secondary Progressive Multiple Sclerosis, Primary Progressive Multiple Sclerosis Trial in Dublin (Fampridine, Placebo)

        Completed
        Has Results
        • Secondary Progressive Multiple Sclerosis
        • Primary Progressive Multiple Sclerosis
        • Dublin, Dublin 4, Ireland
        • +1 more
        Jul 8, 2021

        Multiple Sclerosis Trial (Frexalimab, Placebo, MRI contrast-enhancing agents)

        Not yet recruiting
        • Multiple Sclerosis
        • (no location specified)
        Nov 15, 2023

        Mayzent Onboarding of Secondary Progressive Multiple Sclerosis

        Completed
        • Secondary Progressive Multiple Sclerosis
          • Camperdown, New South Wales, Australia
          • +1 more
          Apr 19, 2023